ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment

BACKGROUND AND PURPOSE—: Poststroke cognitive impairment is a debilitating consequence of stroke. The aim of this study was to assess whether Actovegin confers cognitive benefit in patients who have had an ischemic stroke. METHODS—: This was a 12-month, parallel-group, randomized, multicenter, doubl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stroke
Autors principals: Guekht, Alla, Skoog, Ingmar, Edmundson, Sally, Zakharov, Vladimir, Korczyn, Amos D.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2017
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404405/
https://ncbi.nlm.nih.gov/pubmed/28432265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.014321
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars